96 related articles for article (PubMed ID: 2642628)
1. Renal and hormonal effects of phosphodiesterase III inhibition in congestive heart failure.
Cody RJ
Am J Cardiol; 1989 Jan; 63(2):31A-34A. PubMed ID: 2642628
[TBL] [Abstract][Full Text] [Related]
2. Regional blood flow and neurohormonal responses to milrinone in congestive heart failure.
Cody RJ; Kubo SH; Covit AB; Müller FB; Rutman H; Leonard D; Laragh JH; Feldschuh J; Preibisz J
Clin Pharmacol Ther; 1986 Feb; 39(2):128-35. PubMed ID: 3510799
[TBL] [Abstract][Full Text] [Related]
3. Effects of phosphodiesterase inhibition on skeletal muscle vasculature.
LeJemtel TH; Scortichini D; Levitt B; Sonnenblick EH
Am J Cardiol; 1989 Jan; 63(2):27A-30A. PubMed ID: 2909994
[TBL] [Abstract][Full Text] [Related]
4. Maximizing the renal cyclic 3'-5'-guanosine monophosphate system with type V phosphodiesterase inhibition and exogenous natriuretic peptide: a novel strategy to improve renal function in experimental overt heart failure.
Chen HH; Huntley BK; Schirger JA; Cataliotti A; Burnett JC
J Am Soc Nephrol; 2006 Oct; 17(10):2742-7. PubMed ID: 16928803
[TBL] [Abstract][Full Text] [Related]
5. Direct and indirect assessment of skeletal muscle blood flow in chronic congestive heart failure.
LeJemtel TH; Scortichini D; Katz S
Am J Cardiol; 1988 Sep; 62(8):36E-39E. PubMed ID: 3046291
[TBL] [Abstract][Full Text] [Related]
6. Renal and cardiac function during alpha1-beta-blockade in congestive heart failure.
Heitmann M; Davidsen U; Stokholm KH; Rasmussen K; Burchardt H; Petersen EB
Scand J Clin Lab Invest; 2002; 62(2):97-104. PubMed ID: 12004934
[TBL] [Abstract][Full Text] [Related]
7. Diuretic effect of phosphodiesterase inhibitors depends on baseline renal function in patients with congestive heart failure.
Kanda M; Yasuda S; Goto Y; Sumida H; Baba T; Noguchi T; Nonogi H
Am J Cardiol; 1999 Apr; 83(8):1274-7, A9. PubMed ID: 10215299
[TBL] [Abstract][Full Text] [Related]
8. Acute hemodynamic effects of intravenous sildenafil citrate in congestive heart failure: comparison of phosphodiesterase type-3 and -5 inhibition.
Botha P; Parry G; Dark JH; Macgowan GA
J Heart Lung Transplant; 2009 Jul; 28(7):676-82. PubMed ID: 19560695
[TBL] [Abstract][Full Text] [Related]
9. Regional blood flow responses to vasodilators and inotropes in congestive heart failure.
Leier CV
Am J Cardiol; 1988 Sep; 62(8):86E-93E. PubMed ID: 2901217
[TBL] [Abstract][Full Text] [Related]
10. Amlodipine therapy in congestive heart failure: hemodynamic and neurohormonal effects at rest and after treadmill exercise.
Krombach RS; Clair MJ; Hendrick JW; Mukherjee R; Houck WV; Hebbar L; Kribbs SB; Dodd MG; Spinale FG
Am J Cardiol; 1999 Aug; 84(4A):3L-15L. PubMed ID: 10480440
[TBL] [Abstract][Full Text] [Related]
11. Role of cyclic GMP-inhibitable phosphodiesterase and nitric oxide in the beta adrenoceptor control of renin secretion.
Chiu T; Reid IA
J Pharmacol Exp Ther; 1996 Aug; 278(2):793-9. PubMed ID: 8768733
[TBL] [Abstract][Full Text] [Related]
12. [Central and regional vascular hemodynamics of milrinone in experimental heart failure: comparison with captopril and dobutamine].
Drexler H; Faude F; Winterer H; Wollschläger H; Freudenberg N; Just H
Z Kardiol; 1987 Aug; 76(8):507-13. PubMed ID: 3314215
[TBL] [Abstract][Full Text] [Related]
13. Effect of phosphodiesterase inhibitors on survival of patients with chronic congestive heart failure.
Packer M
Am J Cardiol; 1989 Jan; 63(2):41A-45A. PubMed ID: 2642629
[TBL] [Abstract][Full Text] [Related]
14. Effects of milrinone on renal perfusion, filtration and oxygenation in patients with acute heart failure and low cardiac output early after cardiac surgery.
Lannemyr L; Bragadottir G; Redfors B; Ricksten SE
J Crit Care; 2020 Jun; 57():225-230. PubMed ID: 31919012
[TBL] [Abstract][Full Text] [Related]
15. Renal and hormonal effects of systemic nitric oxide inhibition in patients with congestive heart failure and in healthy control subjects.
Bech JN; Starklint J; Bentzen H; Nyvad O; Pedersen EB
J Card Fail; 2013 Nov; 19(11):776-85. PubMed ID: 24263123
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II AT1 receptor antagonism prevents detrimental renal actions of acute diuretic therapy in human heart failure.
Chen HH; Redfield MM; Nordstrom LJ; Cataliotti A; Burnett JC
Am J Physiol Renal Physiol; 2003 May; 284(5):F1115-9. PubMed ID: 12676739
[TBL] [Abstract][Full Text] [Related]
17. Influence of levosimendan, pimobendan, and milrinone on the regional distribution of cardiac output in anaesthetized dogs.
Pagel PS; Hettrick DA; Warltier DC
Br J Pharmacol; 1996 Oct; 119(3):609-15. PubMed ID: 8894186
[TBL] [Abstract][Full Text] [Related]
18. The effects of olprinone, a phosphodiesterase 3 inhibitor, on systemic and cerebral circulation.
Ueda T; Mizushige K
Curr Vasc Pharmacol; 2006 Jan; 4(1):1-7. PubMed ID: 16472171
[TBL] [Abstract][Full Text] [Related]
19. Role of the kidney in congestive heart failure. Relationship of cardiac index to kidney function.
Ljungman S; Laragh JH; Cody RJ
Drugs; 1990; 39 Suppl 4():10-21; discussion 22-4. PubMed ID: 2354670
[TBL] [Abstract][Full Text] [Related]
20. Pharmacology of positive inotropic phosphodiesterase III inhibitors.
Honerjäger P
Eur Heart J; 1989 Aug; 10 Suppl C():25-31. PubMed ID: 2553411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
